$50 million awarded by CPRIT to MD Anderson and its projects
The University of Texas MD Anderson Cancer Center today was awarded $30 million to support research, core facilities, recruitment and prevention efforts from the Cancer Prevention and Research Institute of Texas (CPRIT). An additional $19.9 million was awarded to a company co-founded by MD Anderson to support the development of a novel targeted therapy to treat neurological conditions caused by chemotherapy. In total, MD Anderson and...
MD Anderson and Accelerator Life Science Partners launch Magnolia Neurosciences to speed development of neuroprotective therapies
The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management...